In order to evaluate the impact of the association between CCND1 gene alteration and the protein inflammasome proteins on the prognosis, we performed Kaplan-Meier curves which revealed that BC patients with positive NLRP3 expression and contextually CCND1 alteration (NLRP3+/CCND1+) had a worse PFS (p = 0.041, Figure 5A) and OS (p = 0.016, Figure 5B) compared to patients with positive NLRP3 expression but without CCND1 gene alteration (NLRP3+/CCND1−. This evidence concerns the gene NLRP3 and breast cancer.